- 4-Week # shares bought: 10,000
- 4-Week # shares sold: 10,000
- 12-Week # shares bought: 10,000
- 12-Week # shares sold: 11,500
- 24-Week # shares bought: 10,000
- 24-Week # shares sold: 17,227
Here are Friday's top research calls, including upgrades for Autodesk and AstraZeneca, and downgrades for Aflac and Duluth.
CEO Chuck Robbins could provide investors with guidance on how the company would deploy a whopping $60 billion in overseas cash.
Here are four stocks to watch with strong technical momentum.
Jim Cramer says UVE is not bad, and he likes AIG and ALL as well.